Biokin Pharmaceutical Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 3,198

Employees

  • Stock Symbol
  • 688506

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $37.80
  • (As of Thursday Closing)

Biokin Pharmaceutical General Information

Description

Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Number 1, Building 1, Number 161, Baili Road
  • Cross-Strait Science and Technology Industrial Park, Wenjiang District
  • Chengdu, Sichuan 610041
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Number 1, Building 1, Number 161, Baili Road
  • Cross-Strait Science and Technology Industrial Park, Wenjiang District
  • Chengdu, Sichuan 610041
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biokin Pharmaceutical Stock Performance

As of 19-Nov-2026, Biokin Pharmaceutical’s stock price is $37.80. Its current market cap is $15.6B with 413M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$37.80 $35.75 $29.58 - $56.98 $15.6B 413M 1.67M -$0.45

Biokin Pharmaceutical Financials Summary

As of 30-Sep-2026, Biokin Pharmaceutical has a trailing 12-month revenue of $370M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 14,937,402 18,725,018 10,062,565 7,901,208
Revenue 369,682 350,438 811,477 79,418
EBITDA (175,598) (105,559) 542,709 (96,866)
Net Income (183,386) (146,512) 516,692 (110,320)
Total Assets 1,995,191 1,636,172 977,707 201,041
Total Debt 982,353 530,854 283,357 96,007
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biokin Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biokin Pharmaceutical‘s full profile, request access.

Request a free trial

Biokin Pharmaceutical Patents

Biokin Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026040176-A1 Composition comprising astragalus membranaceus root extract for soothing, repairing, and moisturizing skin Pending 22-Aug-2024
AU-2023388731-A1 Lightening and moisturizing skin care product composition comprising radix astragali and use thereof Pending 07-Dec-2022
EP-4631495-A1 Lightening and moisturizing skin care product composition comprising radix astragali and use thereof Pending 07-Dec-2022
US-20260207469-A1 Lightening and moisturizing skin care product composition comprising radix astragali and use thereof Pending 07-Dec-2022
WO-2024120417-A1 Lightening and moisturizing skin care product composition comprising radix astragali and use thereof Inactive 07-Dec-2022 A61Q19/00
To view Biokin Pharmaceutical’s complete patent history, request access »

Biokin Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biokin Pharmaceutical Investments (1)

Biokin Pharmaceutical’s most recent deal was a Early Stage VC with Connexus Therapeutics. The deal was made on 17-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Connexus Therapeutics 17-Sep-2026 Early Stage VC Drug Discovery
To view Biokin Pharmaceutical’s complete investments history, request access »

Biokin Pharmaceutical ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

36.51 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Biokin Pharmaceutical’s complete esg history, request access »

Biokin Pharmaceutical FAQs

  • When was Biokin Pharmaceutical founded?

    Biokin Pharmaceutical was founded in 1996.

  • Where is Biokin Pharmaceutical headquartered?

    Biokin Pharmaceutical is headquartered in Chengdu, China.

  • What is the size of Biokin Pharmaceutical?

    Biokin Pharmaceutical has 3,198 total employees.

  • What industry is Biokin Pharmaceutical in?

    Biokin Pharmaceutical’s primary industry is Drug Discovery.

  • Is Biokin Pharmaceutical a private or public company?

    Biokin Pharmaceutical is a Public company.

  • What is Biokin Pharmaceutical’s stock symbol?

    The ticker symbol for Biokin Pharmaceutical is 688506.

  • What is the current stock price of Biokin Pharmaceutical?

    As of 19-Nov-2026 the stock price of Biokin Pharmaceutical is $37.80.

  • What is the current market cap of Biokin Pharmaceutical?

    The current market capitalization of Biokin Pharmaceutical is $15.6B.

  • What is Biokin Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Biokin Pharmaceutical is $370M.

  • What is Biokin Pharmaceutical’s annual earnings per share (EPS)?

    Biokin Pharmaceutical’s EPS for 12 months was -$0.45.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process